Skip to content

AMGEN BIOFARMACEUTICA, LDA — EU public contracts

AMGEN BIOFARMACEUTICA, LDA (Portugal) has won 11 public contracts worth €396.6K in the EU in the last 12 months.

11 awardsPortugal€396.6K

Categories

Pharmaceutical products: 8General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents: 1Various medicinal products: 1Antineoplastic and immunomodulating agents: 1

Awarded contracts

DateBuyerSubjectValueView on TED
13 Oct 2026Unidade Local de Saúde Santa Maria, E.P.E.Portugal – Pharmaceutical products – 2024/0900 - ECULIZUMAB [300 MG SOL INJ FRS]—
24 Jun 2026Unidade Local de Saúde Santa Maria, E.P.E.Portugal – Pharmaceutical products – 2023/0491 - ECULIZUMAB [300 MG SOL INJ FRS]—
24 Jun 2026Unidade Local de Saúde Santa Maria, E.P.E.Portugal – Pharmaceutical products – 2023/0491 - BLINATUMOMAB [38.5 µG PÓ CONC SOL SOL INJ FRS]—
24 Jun 2026Unidade Local de Saúde Santa Maria, E.P.E.Portugal – Pharmaceutical products – 2023/0491 - BLINATUMOMAB [38.5 µG PÓ CONC SOL SOL INJ FRS]—
24 Jun 2026Unidade Local de Saúde Santa Maria, E.P.E.Portugal – Pharmaceutical products – 2023/0491 - ECULIZUMAB [300 MG SOL INJ FRS]—
27 May 2026Unidade Local de Saúde Santa Maria, E.P.E.Portugal – Pharmaceutical products – 2023/0307 - EPOETINAS DE MÉDIA DURAÇÃO [µg FRS/AMP/SERINGA]—
27 May 2026Unidade Local de Saúde Santa Maria, E.P.E.Portugal – Pharmaceutical products – 2023/0307 - EPOETINAS DE MÉDIA DURAÇÃO [µg FRS/AMP/SERINGA]—
27 May 2026Unidade Local de Saúde Santa Maria, E.P.E.Portugal – Pharmaceutical products – 2023/0307 - EPOETINAS DE MÉDIA DURAÇÃO [µg FRS/AMP/SERINGA]—
12 May 2026Unidade Local de Saúde Santa Maria, E.P.E.Portugal – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – 261G000462 - Adalimumab 40 mg/0,4 ml sol inj biossimilar caneta€396.6K
19 Mar 2026Serviços de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM; EPERAM)Portugal – Various medicinal products – IMUNOMODULADORES—
21 Oct 2025Unidade Local de Saúde Santa Maria, E.P.E.Portugal – Antineoplastic and immunomodulating agents – 2023/0491 - BLINATUMOMAB [38.5 µG PÓ CONC SOL SOL INJ FRS]—

See open tenders that fit a company like this

Licitora matches EU public tenders to your company profile every morning. Companies like AMGEN BIOFARMACEUTICA, LDA can save hours of manual search.